Accolade Inc offers technology-enabled solutions that help people understand, navigate, and utilize the healthcare system and their workplace benefits. The company's platform combines open, cloud-based intelligent technology with multimodal support from a team of Accolade Care Advocates and clinicians, including registered nurses, physician medical directors, pharmacists, primary care physicians, and other professionals to provide advocacy, medical opinion, and virtual primary care services.
2007
2.4K+
LTM Revenue $462M
LTM EBITDA $15.4M
$574M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Accolade has a last 12-month revenue of $462M and a last 12-month EBITDA of $15.4M.
In the most recent fiscal year, Accolade achieved revenue of $414M and an EBITDA of -$69.3M.
Accolade expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Accolade valuation multiples based on analyst estimatesFY 2022 | FY 2023 | FY 2024 | LTM | NTM | |
---|---|---|---|---|---|
Revenue | $310M | $363M | $414M | $462M | XXX |
Gross Profit | $141M | $164M | $192M | XXX | XXX |
Gross Margin | 45% | 45% | 46% | XXX | XXX |
EBITDA | -$83.3M | -$117M | -$69.3M | $15.4M | XXX |
EBITDA Margin | -27% | -32% | -17% | 3% | XXX |
Net Profit | -$123M | -$460M | -$99.8M | XXX | XXX |
Net Margin | -40% | -127% | -24% | XXX | XXX |
Net Debt | n/a | n/a | $23.2M | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of February 7, 2025, Accolade's stock price is $7.
Accolade has current market cap of $562M, and EV of $574M.
See Accolade trading valuation dataEV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
---|---|---|---|---|---|---|
$574M | $562M | XXX | XXX | XXX | XXX | $-1.37 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of February 7, 2025, Accolade has market cap of $562M and EV of $574M.
Accolade's trades at 1.2x LTM EV/Revenue multiple, and 37.4x LTM EBITDA.
Analysts estimate Accolade's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Accolade and 10K+ public compsFY 2024 | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|
EV | $574M | XXX | XXX | XXX |
EV/Revenue | 1.3x | XXX | XXX | XXX |
EV/EBITDA | 239.0x | XXX | XXX | XXX |
P/E | -5.6x | XXX | XXX | XXX |
P/E/Growth | n/a | XXX | XXX | XXX |
EV/FCF | 256.2x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpAccolade's NTM/LTM revenue growth is 13%
Accolade's revenue per employee for the last fiscal year averaged $0.2M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, Accolade's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Accolade's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Accolade and other 10K+ public compsFY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
---|---|---|---|---|---|
Revenue Growth | 14% | XXX | XXX | XXX | XXX |
EBITDA Margin | 1% | XXX | XXX | XXX | XXX |
EBITDA Growth | -41% | XXX | XXX | XXX | XXX |
Rule of 40 (SaaS-only) | 13% | XXX | XXX | XXX | XXX |
Revenue per Employee | $0.2M | XXX | XXX | XXX | XXX |
Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
S&M Expenses to Revenue | 24% | XXX | XXX | XXX | XXX |
G&A Expenses to Revenue | 15% | XXX | XXX | XXX | XXX |
R&D Expenses to Revenue | 24% | XXX | XXX | XXX | XXX |
Opex to Revenue | 74% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
EV/Revenue | EV/EBITDA | |||||
---|---|---|---|---|---|---|
2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
Star Health Insurance | XXX | XXX | XXX | XXX | XXX | XXX |
Hapvida | XXX | XXX | XXX | XXX | XXX | XXX |
Qualicorp | XXX | XXX | XXX | XXX | XXX | XXX |
AIX Inc. | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Accolade acquired XXX companies to date.
Last acquisition by Accolade was XXXXXXXX, XXXXX XXXXX XXXXXX . Accolade acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiplesAcquired Company | EV | EV/Revenue | EV/EBITDA |
---|---|---|---|
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign UpWhen was Accolade founded? | Accolade was founded in 2007. |
Where is Accolade headquartered? | Accolade is headquartered in United States of America. |
How many employees does Accolade have? | As of today, Accolade has 2.4K+ employees. |
Who is the CEO of Accolade? | Accolade's CEO is Mr. Rajeev Singh. |
Is Accolade publicy listed? | Yes, Accolade is a public company listed on NAS. |
What is the stock symbol of Accolade? | Accolade trades under ACCD ticker. |
When did Accolade go public? | Accolade went public in 2020. |
Who are competitors of Accolade? | Similar companies to Accolade include e.g. Star Health Insurance, Hapvida, Qualicorp, AIX Inc.. |
What is the current market cap of Accolade? | Accolade's current market cap is $562M |
What is the current revenue of Accolade? | Accolade's last 12-month revenue is $462M. |
What is the current EBITDA of Accolade? | Accolade's last 12-month EBITDA is $15.4M. |
What is the current EV/Revenue multiple of Accolade? | Current revenue multiple of Accolade is 1.2x. |
What is the current EV/EBITDA multiple of Accolade? | Current EBITDA multiple of Accolade is 37.4x. |
What is the current revenue growth of Accolade? | Accolade revenue growth between 2023 and 2024 was 14%. |
Is Accolade profitable? | Yes, Accolade is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.